Annual report
4502.TEDINET S100W07G
Period2024-04-01 → 2025-03-31
Filed2025-06-25
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.58T | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥4.26T | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥4.03T | 2022-04-01 → 2023-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥3.57T | 2021-04-01 → 2022-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥3.20T | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥342.6bn | 2024-04-01 → 2025-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥214.1bn | 2023-04-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥175.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥52.8bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥375.1bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥302.6bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥366.2bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥107.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥144.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥317.0bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥230.1bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥376.0bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥108.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥144.2bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥317.0bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥230.2bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥376.2bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Total assets | ¥14.25T | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥15.11T | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥13.96T | at 2023-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥13.18T | at 2022-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥12.91T | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥7.31T | at 2025-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥7.83T | at 2024-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥6.94T | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥7.27T | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥6.35T | at 2023-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥6.94T | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥7.27T | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥385.1bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥457.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥533.5bn | at 2023-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥849.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥966.2bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥1.06T | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥716.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥977.2bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥1.12T | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥1.01T | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥367.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥463.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥607.1bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥198.1bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥393.5bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥751.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥354.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥709.1bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥1.07T | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥1.09T | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥68.36 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥92.09 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥204.29 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥147.14 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥240.72 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥67.23 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥91.16 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥201.94 | 2022-04-01 → 2023-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥145.87 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥238.96 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥4,407.01 | at 2025-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥4,635.56 | at 2024-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥4,087.49 | at 2023-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,665.61 | at 2022-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,308.93 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 48.7% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.1% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.5% | at 2023-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 43.1% | at 2022-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 40.1% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 1.5% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 2.1% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 5.3% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 4.2% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 7.6% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 47,455 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 49,281 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 49,095 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 47,347 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 47,099 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥580.4bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥595.6bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥632.1bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥764.3bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥602.6bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥36.9bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥48.1bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥86.6bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥286.4bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥340.1bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥550.9bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥50.0bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥199.3bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥391.3bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥152.8bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥338.9bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥330.6bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥324.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥247.5bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥9.49T | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥9.76T | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥9.41T | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥9.64T | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥10.86T | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.50T | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.67T | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.99T | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.09T | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.21T | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥4.29T | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.43T | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥169.6bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥130.9bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥96.79 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥216.6 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥213.06 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥207.5 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥158.45 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥96.78 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥216.56 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥213.05 | 2022-04-01 → 2023-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥207.5 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥158.44 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥196 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥188 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,534.39 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,604.87 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,704.87 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,769.31 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,835.81 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 42.0% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.9% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.7% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.5% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.8% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 3.8% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,590,950,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,582,419,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,582,296,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,582,253,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,576,388,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 4,808 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 5,474 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 5,486 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 5,149 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 4,966 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Businessreportable segment | employees | at 2025-03-31 | 47455 pure |
| Pharmaceutical Businessreportable segment | employees | at 2025-03-31 | 4808 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,774
| Item | Context | Value | Unit |
|---|---|---|---|
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row2Member | － | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | 8119800 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row3Member | 8119800 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | 1307000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row3Member | 1527000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | 1781996 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row4Member | 1781996 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | 83000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row4Member | 823000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | － | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row5Member | 4214559 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | － | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row5Member | 13100000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | － | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row6Member | 3153217 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | － | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row6Member | 5072000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | － | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row7Member | 1096892 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | － | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row7Member | 1025000000 | JPY |
| Number of issues shares not listed investment shares held for pure investment reporting company | CurrentYearInstant | － | |
| Book value equity securities not listed investment equity securities held for pure investment reporting company | CurrentYearInstant | － | JPY |
| Number of issues shares not listed investment shares held for pure investment reporting company | Prior1YearInstant | － | |
| Book value equity securities not listed investment equity securities held for pure investment reporting company | Prior1YearInstant | － | JPY |
| Number of issues shares other than those not listed investment shares held for pure investment reporting company | CurrentYearInstant | － | |
| Book value equity securities other than those not listed investment equity securities held for pure investment reporting company | CurrentYearInstant | － | JPY |
| Number of issues shares other than those not listed investment shares held for pure investment reporting company | Prior1YearInstant | 2 | |
| Book value equity securities other than those not listed investment equity securities held for pure investment reporting company | Prior1YearInstant | 241000000 | JPY |
| Total of dividends received equity securities not listed investment equity securities held for pure investment reporting company | CurrentYearDuration | － | JPY |
| Total of gain loss on sale equity securities not listed investment equity securities held for pure investment reporting company | CurrentYearDuration | － | JPY |
| Total of valuation gain loss equity securities not listed investment equity securities held for pure investment reporting company | CurrentYearDuration | － | JPY |
| Total of dividends received equity securities other than those not listed investment equity securities held for pure investment reporting company | CurrentYearDuration | 5000000 | JPY |
| Total of gain loss on sale equity securities other than those not listed investment equity securities held for pure investment reporting company | CurrentYearDuration | 5000000 | JPY |
| Total of valuation gain loss equity securities other than those not listed investment equity securities held for pure investment reporting company | CurrentYearDuration | － | JPY |
| Revenue IFRS | Prior1YearDuration | 4263762000000 | JPY |
| Revenue IFRS | CurrentYearDuration | 4581551000000 | JPY |
| Cost of sales IFRS | Prior1YearDuration | 1426678000000 | JPY |
| Cost of sales IFRS | CurrentYearDuration | 1580217000000 | JPY |
| Selling general and administrative expenses IFRS | Prior1YearDuration | 1053819000000 | JPY |
| Selling general and administrative expenses IFRS | CurrentYearDuration | 1104766000000 | JPY |
| Research and development expenditure recognized as expense during period IFRS | Prior1YearDuration | 729924000000 | JPY |
| Research and development expenditure recognized as expense during period IFRS | CurrentYearDuration | 730227000000 | JPY |
| Amortization and impairment losses on intangible assets associated with products IFRS | Prior1YearDuration | 652117000000 | JPY |
| Amortization and impairment losses on intangible assets associated with products IFRS | CurrentYearDuration | 643233000000 | JPY |
| Other operating income IFRS | Prior1YearDuration | 19379000000 | JPY |
| Other operating income IFRS | CurrentYearDuration | 26212000000 | JPY |
| Other operating expenses IFRS | Prior1YearDuration | 206527000000 | JPY |
| Other operating expenses IFRS | CurrentYearDuration | 206733000000 | JPY |
| Operating profit loss IFRS | Prior1YearDuration | 214075000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |